Abstract 4941: TTF1 negative in non small cell lung cancer adenocarcinoma: A prognostic factordoi:10.1158/1538-7445.AM2019-4941lung adenocarcinoma (ADC), non small cell lung cancer (NSCLC), epidermal growth factor receptor (EGFR), prognosis in thyroid transcription factor 1 negative (TTF1) ...
TTF-1在小细胞肺癌和肺腺癌中的表达及其临床意义
deathinducing, and dominantnegative activitiesMolecular Cell, 1998, 2(3):305316。 [10]Altaner S, Yoruk Y, Tokatli F, et al The correlation between TTF1 immunoreactivity and the occurrence of lymph node metastases in patients with lung , 2006, 92 ...
肺癌是原发于支气管-肺的肿瘤,是当前世界人类最常见的恶性肿瘤之一,约占所有恶性肿瘤的16%,约占全部癌症死亡的25%-30%。通常,肺癌分为小细胞肺癌(small-celllungcancer,SCLC)和非小细胞肺癌(non-small-celllungcancer,NSCLC)两大类,其中非小细胞肺癌约占全部肺癌的80%-85%,患者5年生存率低于15%[1]。如今,...
lung cancer,squamous cell carcinoma,adenocarcinoma and large cell carcinoma.It is of no value to distinguishing squamous carcinoma from ad 英文摘要 combined detection of CK7、CK5 and TTF一1 expression in distinguishing adenocarcinoma from squamous cell carcinoma. Methods:78 cases consisting of 64 cases...
CK7与CK5和TTF-1用于肺腺癌和肺鳞癌鉴别的临床价值
脉期\……与Ki>67表达呈负相关，间接反映肿瘤血供及增殖活性，为临床下一步诊疗提供参考;并能在一定程度上 预测Ki-67表达;TTF-1表达与双能量参数无明显相关性。【关键词】肺癌双能量CT Ki>67 TTF-1 The Predicting Value of Dual-Energy CT for the Expression Level of Ki-67 and TTF-1 in Lung Cancer ...
9. P63, a P53 Homolog at 3q27-29, Encodes Multiple Products with Transactivating, Death-Inducing, and Dominant-Negative Activities.[J].Kaghad M;Andrews NC;Yang A;Dotsch V;Wang Y;Gillett E;McKeon F;Fleming MD;Caput D,Molecular cell.1998,第3期 10. Prognostic value of ...
8. Negative Thyroid Transcription Factor 1 Expression Defines an Unfavorable Subgroup of Lung Adenocarcinomas[J].Chen; Haiquan;Yu; Yongfu;Pan; Yunjian;Shen; Lei;Zhang; Yiliang;Hu; Haichuan;Sun; Yihua;Li; Hang;Zhang; Yang;Li; Yuan;Wang; Rui,Journal of thoracic oncology: official publication ...
age—specifi c onc ogene in NSC LC :Implications i n lung cancer pat hogene- sis and prognosis[J ].Clin Can cer Res,2011,17( 8) :2434_2443. [ 14] Vincenten J,Smit EF ,Vos W,et a1 .Negative NKX2-1 ( TTF·1) as temporary surrogate marker for treatment selec tion duri ng E...